Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. E.M.D. (Ed) Schuuring
University Medical Center Groningen

prof. dr. E.M.D. (Ed) Schuuring

Hoogleraar in de Moleculaire Oncologische Pathologie

Publicaties

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling

Trends in cervical cancer incidence in the Netherlands: A join-point and age–period–cohort analysis (1989–2023)

Authors' Reply “Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib

Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Distribution of Human Papillomavirus Genotypes in Real-World Cervical Self-Collected Scrapings From the Dutch Cervical Cancer Screening Program

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

Pers/media

Nieuwe Groningse test voorkomt duizenden fouten bij opsporen baarmoederhalskanker

European Liquid Biopsy Society geeft advies over de rapportage van ctDNA-testuitslagen

Highlights cfDNA

De praktische meerwaarde van de KNT-lijsten.

Delivering molecular pathology at lower costs

cieBOD adviseert over de primaire predictieve analyse van ctDNA in bloedplasma bij mNSCLC.

Moleculaire Tumor Board (MTB)